Efforts to reduce opioid-related deaths by restricting access to pain medication seem to be backfiring by driving people toward more dangerous drugs. Two analyses published today provide more reason to be skeptical of this approach,

( Prescription drug monitoring programs — believed to be an important tool in the fight against the opioid epidemic — may be only marginally effective in reducing overdose deaths, according to a new study. But

( The National Center for Health Statistics reported last month that a record 63,600 deaths occurred in 2016 due to overdoses. Digging deeper into that number shows over 20,000 of those deaths were due to

( Millions of chronic pain patients who use prescription opioids so that they can work, sleep, bathe and do simple household chores would quickly answer “Yes” to those questions. But that’s a radical concept in

1. Pediatric unintentional opioid exposures decreased by more than 75% following the introduction of child-resistant unit-dose packaging (UDP). 2. More than 20% of unintentional buprenorphine-naloxone exposures in children  Study Rundown: In the past 2 decades,

( An analysis of opioid-related overdose deaths found that synthetic opioids, such as illicit fentanyl, have surpassed prescription opioids as the most common drug involved in overdose deaths in the U.S. A research letter published